ESC 365 - Antithrombotic treatment of patients undergoing TAVI.

ESC Premium Access

Antithrombotic treatment of patients undergoing TAVI.

Session: Prevention and treatment of bioprosthetic valve failure

Topic: Noncoronary Cardiac Intervention

Speaker: Professor R. Mehran (New York, US)

Event: ESC Congress 2018

Presentation

About the speaker

Professor Roxana Mehran

Icahn School of Medicine at Mount Sinai, New York (United States of America)

29 presentations

1 follower

3 more presentations in this session

Degeneration of mitral valve bioprostheses: incidence, mechanisms, diagnosis

Speaker: Doctor N. Karam (Paris, FR)

Solutions for the failed mitral bioprosthesis

Speaker: Professor V. Rudolph (Bad Oeynhausen, DE)

Treatment of TAVI thrombosis - Current evidence

Speaker: Doctor D. Jochheim (Hattingen, DE)

Access the full session

Prevention and treatment of bioprosthetic valve failure

Speakers: Professor R. Mehran, Doctor N. Karam, Professor V. Rudolph, Doctor D. Jochheim

About the event

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress

Related content

EACVI Premium Access

Diagnosing MAC-related mitral stenosis: gradient, area or both?

9 December 2021

ESC Premium Access

Management of endocarditis: state of the art

28 August 2021

This platform is supported by